https://dormaj.org/index.php/JIRB/issue/feed Journal of Infertility and Reproductive Biology 2022-09-29T03:18:04-05:00 Dr. Sanaz Alaee jirb@dormaj.org Open Journal Systems <p><strong><span lang="EN-GB">Journal of Infertility and Reproductive Biology (JIRB)</span></strong></p> <p><strong><span lang="EN-GB">ISSN:</span></strong><span lang="EN-GB">&nbsp;2310-7588</span></p> <p style="text-align: justify;">Journal of Infertility and Reproductive Biology (JIRB) is a quarterly, peer-reviewed, open access, and free of charge journal that publishes original research articles as well as review articles in all areas of infertility and reproductive sciences. This journal was financed by&nbsp;<span class="SpellE">D</span><span class="SpellE">orma</span>&nbsp;Trading&nbsp;<span class="SpellE">Est</span>, publisher<a href="http://www.dormaj.com">,</a>&nbsp;Dubai, United Arab Emirates, and Jami Institute of Technology, Isfahan, Iran.&nbsp;JIRB is an Open Access Journal Database&nbsp;<span class="il">for</span>&nbsp;the high visibility and promotion of your articles. JIRB is steered by a distinguished&nbsp;<a href="https://dormaj.com/index.php/JIRB/about/editorialTeam">Board of Editors</a>&nbsp;and is supported by an international reviewer team consisting of prominent individuals representing many well-known universities, colleges, and corporations in Germany, Spain, Korea, India, Bangladesh, and many more.<strong>&nbsp;</strong>To maintain a high-quality journal, manuscripts that appear in the JIRB Articles section have been subjected to a rigorous review process. This includes blind reviews by three or more members of the international editorial review team, followed by a detailed review by the JIRB editors. The JIRB has been financially and scientifically supported by <a href="http://en.jamiuni.ir/">the Jami Institute of Technology</a>. The Journal welcomes original research contributions (previously unpublished) from all established areas of infertility and reproductive sciences.&nbsp;</p> https://dormaj.org/index.php/JIRB/article/view/10.47277%2FJIRB%2F10%283%29%2F57 Subcutaneous Infiltration of Gentamycin Saline Solution to Reduce Rates of Cesarean Section Surgical Site Infection in Primigravidas Scheduled for Elective Cesarean Section 2022-09-29T03:18:04-05:00 Mostafa Abdulla Elsayed Mahmoud mostafaabdulla7@gmail.com <p>Cesarean section is a daily practice with the incidence in Egypt exceeding 40 percent, surgical site infection is uncommon morbidity, and efforts made extensively to lower the infection rate the presented work aimed at lowering surgical site infection in cesarean section with the use of gentamycin solution preclosure <em>to </em>reduce CS-SSI rates. The presented work was a controlled trial involving 200 cases of elective cesarean section done in Zinat Alhyat hospital for delivery in Benha city. Two hundred cases recruited from Zinat al-Hayat hospital in Benha were divided into two groups: group one [gentamycin group] hundred cases receiving pre-closure irrigation of the subcutaneous tissue with gentamycin vial 40mg diluted in 10 ml syringes then closing the wound with prolene sutures. Group 2 hundred cases not [control non-intervention] receiving gentamycin infiltration and taken as the control group the wound closed with prolene sutures without infiltration with gentamycin. Written consent was signed by all participants in the trial. The study gave the following. Cesarean section surgical site infection dropped from 8 percent in the control group to 1 percent in the trial group with gentamycin. Surgical site infection post-cesarean section can be reduced by subcutaneous infiltration with gentamycin saline solution.</p> 2022-09-29T03:10:42-05:00 ##submission.copyrightStatement##